Caredx Inc sell nvestor
Start price
04.03.23
/
50%
€8.50
Target price
04.03.24
€4.00
Performance (%)
-13.49%
End price
16.09.23
€7.35
Summary
This prediction ended on 16.09.23 with a price of €7.35. The price of Caredx Inc decreased from the start of the prediction. Compared to the start price this resulted in a performance of -13.49%. nvestor has 50% into this predictionCareDx is a publicly traded biotechnology company that specializes in providing innovative transplant solutions for patients suffering from various diseases. The company has developed a range of diagnostic solutions that help doctors monitor the health of organ transplant recipients, including tests that can detect early signs of organ rejection. CareDx has a strong track record of developing cutting-edge medical technologies and working with leading healthcare providers to improve patient outcomes. As a publicly-listed company, CareDx has a diverse shareholder base and is subject to the scrutiny of regulatory bodies, providing transparency and accountability to investors.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Caredx Inc | 39.416% | 39.416% | 16.392% | 135.802% |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % | 49,83 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % | 89,76 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % | 64,38 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % | 64,25 % |